Approval · Notice of Compliance 9874 · 2008
DOVOBET: Notice of Compliance 9874
Issued November 6, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9874
- Date
- November 6, 2008
- Company
- Leo Pharma IncToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Revisions to the indications and clinical use, warnings and precautions, adverse reactions, dosage and administration, and clinical trials sections of the product monograph
- Therapeutic class
- Topical antipsoriatic agent, vitamin d analogue, corticosteroid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DOVOBET | Not yet assigned | — |
Medicinal ingredients
- BETAMETHASONE DIPROPIONATE 0.5 MG per G
- CALCIPOTRIOL 50 MCG per G